Diseases And Conditions


Abdominal Pain
Acute Leukemia
Acute Pyelonephritis
Acute Tubular Necrosis
Adenoid Hyperplasia
Adenovirus Infection
Amebiasis
Amnesia
Ascariasis
Atelectasis
Backache Nechache
Basal Cell Epithelioma
Benign Prostatic Hyperplasia
Blastomycosis
Breathlessness
Brucellosis
Candidiasis
Carpal Tunnel Syndrome
Chest Pain
Chronic Fatigue Immune Dysfunction Syndrome
Clostridium Difficile Infection
Coccidioidomycosis
Colorado Tick Fever
Cough
Cryptococcosis
Cryptosporidiosis
Cyanosis
Cystinuria
Diarrhoea
Dys Somnia
Ebola Virus Infection
Edema
Effects of Cold
Enterobiasis
Epididymits
Epilepsy
Epistaxis
Fainting
Fatigue
Fibrocystic Breast Disease
Fibromyalgia
Galactorrhea
Gas Gangrene
Giardiasis
Gonorrhea
Hallux-valgus
Hantavirus Pulmonary Syndrome
Headache
Heartburn
Hematemesis Melena
Hematuria
Hemoptysis
Herpangina
Hiccups
Hirschsprungs Disease
Histoplasmosis
Hyperemesis Gravidarum
Hypersomnia
Infectious Myringitis
Insomnia
Jaundice
Juvenile Angiofibroma
Legg Calve Perthes Disease
Legionnaires Disease
Listeriosis
Loss of Appetite
Migraine
Mouth Sores
Multiple Myeloma
Necrotizing Faciitis
Neurogenic Arthropathy
Osgood Schlatter Disease
Otitis-externa
Ovarian Cyst
Pale Skin
Parainfluenza
Parasomnias
Pilonidal Disease
Poliomyelitis
Proctitis
Pseudomonas Infection
Rectal Prolapse
Renovascular Hypertension
Roseola Infantum
Schistosomiasis
Shigellosis
Sneezing
Snoring
Sporotrichosis
Strongyloidiasis
Taeniasis
Testicular Torsion
Toxoplasmosis
Tracheoesophageal Fistula
Travel Sickness
Trichomoniasis
Urinary Disorders
Varicella
Vertigo
Vesicoureteral Reflux
Vomiting
West Nile Encephalitis


Cryptococcosis


Cryptococcosis is a rare fungal infection.Cryptococcosis caused by inhaling the fungus Cryptococcus neoformans. Cryptococcus neoformans is an encapsulated round to oval yeastlike fungus measuring six microns. A characteristic polysaccharide capsule of variable thickness surrounds these yeasts. In its natural enviroment the capsule is thinner and the yeast smaller, while thicker capsules tend to be found from infected tissues. The polysaccharide capsule, the phenoloxidase enzyme of Cryptococcus neoformans , and the organism's ability to grow at 37°C, are its major virulence factors It is present around the world, but infection was relatively rare until the aids epidemic began. The fungus sometimes infects people with Hodgkin's disease or sarcoidosis and those who are on long-term corticosteroid treatment. Cryptococcosis mainly occurs in the tissues covering the brain and spinal cord , resulting in meningitis; in the lungs; and on the skin. Other organs are sometimes involved. the fungus usually shows a predilection for the central nervous system, however skin, bones and other visceral organs may also become involved. Although Cryptococcus neoformans is regarded as the principle pathogenic species, Cryptococcus albidus and Cryptococcus laurentii have on occasion also been implicated in human infection. Cryptococcus neoformans has two varieties- Neoformans and gattii . The species has four serotypes based on antigenic specificity of the capsular polysaccharide. The Cryptococcus neoformans var neoformans is the most common variety in the United States and other temperate climates throughout the world and.It is found in aged pigeon droppings. Cryptococcus neoformans var gattii develops in tropical and subtropical climates and is not associated with birds, but it grows in the litter around certain species of eucalyptus trees. there are major varieties with differing biological, ecological, and epidemiological characteristics For many years.

In humans Cryptococcus neoformans affects immunocompromised hosts predominantly and is the commonest cause of fungal meningitis. Worldwide ten percentage of patients with AIDS are affected. In patients with AIDS, skin manifestations represent the second most common site of disseminated cryptococcosis. A causes most cryptococcal infections in patients who are immunocompromised. In contrast, the distribution of cryptococcosis due to Cryptococcus gattii is geographically restricted, non-immunocompromised hosts are usually affected, large mass lesions in lung and/or brain are characteristic and morbidity from neurological disease is high. Cryptococcus has been reported from the respiratory tract, especially sputum and from skin in healthy people as a result of normal environmental exposure. cryptococcosis may occur in some patients when primary infections may not readily resolve in some patients, leading to a more chronic pneumonia progressing slowly over several years. Patients may become pyrexic and have an accompanying cough, however many pulmonary lesions are often asymptomatic, especially when chronic granulomas are formed. Chronic pulmonary cryptococcosis also increases the risk of dissemination to the central nervous system. Osseous cryptococcosis occurs in up to 10% of disseminated cases and may involve bony prominences, cranial bones and vertebrae. The lesions are lytic without periosteal reaction and symptoms of dull pain on movement are reported. Occasional cases of arthritis have also been reported, mostly involving the knee joint. Cryptococcus neoformans is often isolated from urine of patients with disseminated infection. Occasionally, signs of pyelonephritis or prostatitis may be observed

Causes of Cryptococcosis

Common causes of Cryptococcosis

  • Infection.
  • Spread throughout the body.
  • Tumor-like masses.
  • Spinal cord.
  • Cerebellum.

Symptoms of Cryptococcosis

Common symptoms of Cryptococcosis

  • Intracranial mass.
  • Include headache.
  • Drowsiness.
  • Nausea.
  • Vomiting.
  • Mental changes.
  • Slurred speech.
  • Double vision.
  • Unsteadiness of gait.
  • Fever.
  • Headache.
  • Loss of appetite.
  • Bruises.
  • Cough.

Treatment of Cryptococcosis

Common Treatment of Cryptococcosis

  • Hematogenous spread to the central nervous system has a severe and often fatal course, especially in debilitated patients.
  • Patients with mild to moderate severity culture-positive non-CNS infections can be treated with fluconazole or itraconazole for 6 to 12 months
  • Discontinuation of Antifungal Therapy for Cryptococcosis after Immunologic Response to Antiretroviral Therapy.
  • AIDS patients with either pulmonary should be treated as mentioned above.Until recently, It was recommended that AIDS patients be placed on a lifelong maintenance antifungal regimen, with fluconazole.

 

 

 

Copyright © 2006 Health Care Guide. All Rights Reserved.

Disclaimer :- The information contained in this web site is for educational purposes only and is not intended or implied to be a substitute for professional medical advice. It is not a substitute for professional medical advice. For specific medical advice, diagnoses, and treatment, please consult your doctor.